L. M. Barat and P. B. Bloland, DRUG RESISTANCE AMONG MALARIA AND OTHER PARASITES, Infectious Disease Clinics of North America, vol.11, issue.4, pp.969-987, 1997.
DOI : 10.1016/S0891-5520(05)70400-1

M. J. Blackman, T. J. Scott-finntgan, S. Shai, and A. A. Holder, Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein, Journal of Experimental Medicine, vol.180, issue.1, pp.389-393, 1994.
DOI : 10.1084/jem.180.1.389

S. P. Chang, S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer et al., A recombinant baculovirus 42-kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria, Infect. Immun, vol.64, pp.253-261, 1996.

J. A. Chappel and A. A. Holder, Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1, Molecular and Biochemical Parasitology, vol.60, issue.2, pp.303-311, 1993.
DOI : 10.1016/0166-6851(93)90141-J

M. G. Cunha, M. M. Rodrigues, and I. S. Soares, Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors, Vaccine, vol.20, issue.3-4, pp.385-396, 2001.
DOI : 10.1016/S0264-410X(01)00359-0

D. Portillo, H. A. Longacre, S. Khouri, E. David, and P. H. , Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species., Proceedings of the National Academy of Sciences, vol.88, issue.9, pp.4030-4034, 1991.
DOI : 10.1073/pnas.88.9.4030

A. F. Egan, M. J. Blackman, and D. C. Kaslow, Vaccine Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein 1 in Malaria-Naive, -Exposed, and/or -Rechallenged Aotus vociferans Monkeys, Infection and Immunity, vol.68, issue.3, pp.1418-1427, 2000.
DOI : 10.1128/IAI.68.3.1418-1427.2000

T. Fraser, P. Michon, J. W. Barnwell, A. R. Noe, F. Al-yaman et al., Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein, Infect. Immun, vol.65, pp.2772-2777, 1997.

R. R. Freeman and A. A. Holder, Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites, Journal of Experimental Medicine, vol.158, issue.5, pp.1647-1653, 1983.
DOI : 10.1084/jem.158.5.1647

M. U. Ferreira, E. A. Kimura, J. M. De-souza, and A. M. Katzin, The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients, Am. J. Trop. Med. Hyg, vol.55, pp.315-323, 1996.

M. U. Ferreira, W. L. Ribeiro, A. P. Tonon, F. Kawamoto, and S. M. Rich, Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum, Gene, vol.304, pp.65-75, 2003.
DOI : 10.1016/S0378-1119(02)01180-0

M. R. Galinski and J. W. Branwell, Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development, Parasitology Today, vol.12, issue.1, pp.20-29, 1996.
DOI : 10.1016/0169-4758(96)80641-7

H. J. Han, S. G. Park, S. H. Kim, S. Y. Hwang, J. Han et al., Epidermal growth factor-like motifs 1 and 2 of Plasmodium vivax merozoite surface protein 1 are critical domains in erythrocyte invasion, Biochemical and Biophysical Research Communications, vol.320, issue.2, pp.563-570, 2004.
DOI : 10.1016/j.bbrc.2004.06.008

K. Hedman, M. Lappalainen, I. Seppaia, and O. Makela, Recent Primary Toxoplasma Infection Indicated by a Low Avidity of Specific IgG, Journal of Infectious Diseases, vol.159, issue.4, pp.736-740, 1989.
DOI : 10.1093/infdis/159.4.736

A. A. Holder, M. J. Blackman, P. A. Burghaus, J. A. Chappel, I. T. Ling et al., A malaria merozoite surface protein (MSP1)-structure, processing and function, Mem??rias do Instituto Oswaldo Cruz, vol.87, pp.37-42, 1992.
DOI : 10.1590/S0074-02761992000700004

M. C. Leclerc, M. Menegon, A. Cligny, J. L. Noyer, S. Mammadov et al., Genetic diversity of Plasmodium vivax isolates from Azerbaijan, Malaria Journal, vol.3, issue.1, p.40, 2004.
DOI : 10.1186/1475-2875-3-40

C. S. Lim, S. H. Kim, S. I. Kwon, J. W. Song, K. J. Song et al., Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates, Am. J. Trop. Med. Hyg, vol.62, pp.261-265, 2000.

K. J. Lim, J. W. Park, J. S. Yeom, Y. H. Lee, S. B. Yoo et al., Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax, Parasitol. Res, vol.92, pp.384-389, 2004.

K. Mendis, B. J. Sina, P. Marchesini, and R. Carter, The neglected burden of Plasmodium vivax malaria, Am. J. Trop. Med. Hyg, vol.64, pp.97-106, 2001.

C. G. Morais, I. S. Soares, L. H. Carvallo, C. J. Fontes, A. U. Krettli et al., IgG isotype to C-terminal 19???kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil, Parasitology Research, vol.28, issue.6, pp.420-426, 2005.
DOI : 10.1007/s00436-005-1314-x

P. A. Nogueira, F. P. Alves, C. Fernandez-becerra, O. Pein, N. R. Santos et al., A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1, Infection and Immunity, vol.74, issue.5, pp.2726-2733, 2006.
DOI : 10.1128/IAI.74.5.2726-2733.2006

T. Nomura, J. M. Carlton, J. K. Baird, D. Portillo, H. A. Fryauff et al., Species That Cause Human Malaria, The Journal of Infectious Diseases, vol.183, issue.11, pp.1653-1661, 2001.
DOI : 10.1086/320707

J. W. Park, S. H. Moon, J. S. Yeom, K. J. Lim, M. J. Sohn et al., Naturally Acquired Antibody Responses to the C-Terminal Region of Merozoite Surface Protein 1 of Plasmodium vivax in Korea, Clinical and Vaccine Immunology, vol.8, issue.1, pp.14-20, 2001.
DOI : 10.1128/CDLI.8.1.14-20.2001

N. Pitabut, J. Panichakorn, Y. Mahakunkijcharoen, C. Hirunpetcharat, S. Looareesuwan et al., IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria, Southeast Asian J. Trop. Med. Public. Health, vol.38, pp.1-7, 2007.

C. Putaporntip, S. Jongwutiwes, N. Sakihama, M. U. Ferreira, W. G. Kho et al., Mosaic organization and heterogeneity in frequency of allelic re-combination of the Plasmodium vivax merozoite surface protein-1 locus, Proc. Natl. Acad. Sci. U.S.A. 99, pp.16348-16353, 2002.

L. E. Rodriguez, M. Urquiza, M. Ocampo, H. Curtidor, J. Sua??rezsua??rez et al., Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes, Vaccine, vol.20, issue.9-10, pp.1331-1339, 2002.
DOI : 10.1016/S0264-410X(01)00472-8

H. P. Roost, M. F. Bachmann, A. Haag, U. Kalinke, V. Pliska et al., Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity., Proceedings of the National Academy of Sciences, vol.92, issue.5, pp.1257-1261, 1995.
DOI : 10.1073/pnas.92.5.1257

S. Sachdeva, G. Ahmad, P. Malhotra, P. Mukherjee, and V. S. Chauhan, Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli, Infection and Immunity, vol.72, issue.10, pp.5775-5782, 2004.
DOI : 10.1128/IAI.72.10.5775-5782.2004

C. Severini, M. Menegon, D. Luca, M. Abdullaev, I. Majori et al., Risk of Plasmodium vivax malaria reintroduction in Uzbekistan: genetic characterization of parasites and status of potential malaria vectors in the Surkhandarya region, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.98, issue.10, pp.585-592, 2004.
DOI : 10.1016/j.trstmh.2004.01.003

G. Snounou, S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro et al., High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction, Molecular and Biochemical Parasitology, vol.61, issue.2, pp.315-320, 1993.
DOI : 10.1016/0166-6851(93)90077-B

I. S. Soares, G. Levitus, J. M. Souza, D. Portillo, H. A. Rodrigues et al., Acquired immune responses to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria, Infect. Immun, vol.65, pp.1606-1614, 1997.

I. S. Soares, M. G. Da-cunha, M. N. Silva, J. M. Souza, D. Portillo et al., Longevity of naturally acquired antibody responses to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1, Am. J. Trop. Med. Hyg, vol.60, pp.357-363, 1999.

M. C. Suárez-mutis, P. Cuervo, F. M. Leoratti, S. L. Moraes-avila, A. W. Ferreira et al., Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil, Revista do Instituto de Medicina Tropical de S??o Paulo, vol.49, issue.3, pp.159-164, 2007.
DOI : 10.1590/S0036-46652007000300005

J. H. Tian, S. Kumar, D. C. Kaslow, and L. H. Miller, Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii, Infect. Immun, vol.65, pp.3032-3036, 1997.

K. Tanabe, M. Mackay, M. Goman, and J. G. Scaife, Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum, Journal of Molecular Biology, vol.195, issue.2, pp.273-287, 1987.
DOI : 10.1016/0022-2836(87)90649-8

C. Uthaipibull, B. Aufiero, S. E. Syed, B. Hansen, J. A. Guevara-patino et al., Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum11Edited by J. A. Wells, Journal of Molecular Biology, vol.307, issue.5, pp.1381-1394, 2001.
DOI : 10.1006/jmbi.2001.4574

T. Wickramarachchi, R. J. Illeperuma, L. Perera, S. Bandara, I. Holm et al., Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka, International Journal for Parasitology, vol.37, issue.2, pp.199-208, 2007.
DOI : 10.1016/j.ijpara.2006.09.002

C. Yang, W. E. Collins, J. S. Sullivan, D. C. Kasalow, L. Xiao et al., Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant, Infect. Immun, vol.67, pp.342-349, 1999.

S. Zakeri, S. T. Najafabadi, A. Zare, and N. D. Djadid, Detection of malaria parasites by nested PCR in south-eastern, Iran: Evidence of highly mixed infections in Chahbahar district, Malar. J, vol.1, issue.2, 2002.

S. Zakeri, S. Mamaghani, A. A. Mehrizi, Z. Shahsavari, A. Raeisi et al., Molecular evidence of mixed P. vivax and P. falciparum infections in northern Islamic Republic of Iran, East. Mediterr. Health. J, vol.10, pp.336-342, 2004.

S. Zakeri, A. A. Mehrizi, S. Mamaghani, S. Noorizadeh, G. Snounou et al., Population structure analysis of Iranian Plasmodium vivax in areas with different malaria endemicity, Am. J. Trop. Med. Hyg, vol.74, pp.394-400, 2006.

F. Y. Zeyrek, A. Babaoglu, S. Demirel, D. D. Erdogan, M. Ak et al., Short report: analysis of naturally acquired antibody responses to the 19- kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am. J. Trop. Med. Hyg, vol.78, pp.729-732, 2008.